REMICADE

This brand name is authorized in Nigeria. It is also authorized in Australia, Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Germany, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Tunisia, Turkey, UK, United States.

Active ingredients

The drug REMICADE contains one active pharmaceutical ingredient (API):

1	Infliximab UNII B72HH48FLU - INFLIXIMAB
	Infliximab is a chimeric human-murine monoclonal antibody that binds with high affinity to both soluble and transmembrane forms of TNFα but not to lymphotoxin α (TNFβ).
	Read more about Infliximab

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A6-0490	Powder for solution for injection/infusion	Remicade INJ_PWD_F_SOL 100 mg 100mg x 1	Formulated Powder for concentrate for solution for infusion (powder for concentrate). The powder is a freeze-dried white pellet.	27/06/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AB02	Infliximab	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
Discover more medicines within L04AB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10057H, 10067W, 10184B, 10196P, 11389K, 11399Y, 11412P, 11424G, 11445J, 11448M, 11459D, 11481G, 11482H, 11487N, 11489Q, 11497D, 11498E, 11590B, 11606W, 11797X, 4284L, 5753T, 5754W, 5755X, 5756Y, 5757B, 5758C, 6397Q, 6448J, 6496X, 9612X, 9613Y, 9617E, 9654D, 9674E
BR	Câmara de Regulação do Mercado de Medicamentos	514512080025214
CA	Health Products and Food Branch	02244016
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00067808, 00072181, 00200213, 00200236, 01359648, 01359654, 01557414, 01574335, 02001630, 02001653, 02144565, 02144571, 02645356, 02645362, 03332091, 03572300, 03572317, 03741240, 03767883, 04113876, 05461591, 05497293, 05497301, 05515795, 05515803, 05874034, 05874040, 06105800, 06105817, 06113343, 06140110, 06407180, 06453607, 06464752, 06464769, 06561395, 06561403, 06765778, 06939959, 07510371, 07796404, 08453557, 08453563, 08453586, 08453592, 09094876, 09245140, 10709231, 10822631, 10978899, 10985942, 11022507, 11024185, 11072511, 11078353, 11098580, 12444400, 12444417, 13582908, 14227434, 14259948, 14259954, 14277656, 15390053, 15390076, 15390082, 15390099, 15390107, 15433911, 15433928, 15433934, 15559919, 15658165, 15658171, 15658188, 15658194, 16383233, 16451822, 16451845, 16667367, 16743737, 16743743, 16743766, 16830092, 16830100
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	57-MBE-0516
EE	Ravimiamet	1010833, 1111116, 1111127, 1430648, 1430659
ES	Centro de información online de medicamentos de la AEMPS	99116001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	063187, 575787
FR	Base de données publique des médicaments	64542736
GB	Medicines & Healthcare Products Regulatory Agency	392468, 43981
HK	Department of Health Drug Office	54964
IL	מִשְׂרַד הַבְּרִיאוּת	4184
IT	Agenzia del Farmaco	034528012
JP	医薬品医療機器総合機構	2399402F1026
LT	Valstybinė vaistų kontrolės tarnyba	1007116, 1030651, 1030652, 1036689, 1036690
NG	Registered Drug Product Database	A6-0490
NL	Z-Index G-Standaard, PRK	54542
NZ	Medicines and Medical Devices Safety Authority	8822
PL	Rejestru Produktów Leczniczych	100104274
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W57617001, W57617002, W57617003, W57617004, W57617005
SG	Health Sciences Authority	12120P
TN	Direction de la Pharmacie et du Médicament	1923011H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699636790380
US	FDA, National Drug Code	57894-030